首页
外语
计算机
考研
公务员
职业资格
财经
工程
司法
医学
专升本
自考
实用职业技能
登录
外语
On October 2nd, Ashoka Mukpo left his father a voice mail from Monrovia, saying he had "unwelcome but not unexpected news. " Muk
On October 2nd, Ashoka Mukpo left his father a voice mail from Monrovia, saying he had "unwelcome but not unexpected news. " Muk
admin
2019-07-19
38
问题
On October 2nd, Ashoka Mukpo left his father a voice mail from Monrovia, saying he had "unwelcome but not unexpected news. " Mukpo, an American freelance camera-man for NBC News, had tested positive for Ebola virus. Mukpo’s father, Mitchell Levy, a pulmonologist who heads critical care at Rhode Island Hospital in Providence, immediately helped arrange his son’s transfer to the Nebraska Medical Center in Omaha, one of the four specialized Ebola centres in the United States.
The big question then was how to treat the patient.
The medical team, which included Levy, planned to intensively monitor Mukpo and give him intravenous replacement of fluids and electrolytes, antibiotics to combat also had three unproven treatments available. TKM-Ebola, which inhibits viral RNA, has worked beautifully in monkeys, the best animal model. Kent Brantly, a missionary doctor in Liberia who developed Ebola and recovered, offered to donate plasma removed from his blood, which contained antibodies that might help. And there was brincidofovir, a drug being developed for other viral infections that has been shown to stop Ebola virus in test tubes. The most famous drug candidate, ZMapp, was not available at the time. After careful consideration, Mukpo and his doctors opted to use the serum—a proven intervention with other viruses—and brincidofovir, which has a substantial safety record. But they decided to forgo TKM-Ebola, despite its promise, because of worries that it could trigger overproduction of cytokines, a dangerous inflammatory response also caused by the Ebola virus, and scant data from human trials. "I was not quite on my deathbed and didn’t need to take any huge risks," Mukpo says. His doctor father had reached a similar conclusion. "I didn’t have a high degree of confidence that brincidofovir was going to work, but I was loath to try an investigational agent with no data," Levy says.
Mukpo survived, but no one has any idea whether the experimental treatments helped him, did nothing, or even slowed his recovery. The same is true for Brandy and 17 other Ebola patients who received experimental interventions in the United States and Europe.(One other Ebola patient was treated in Germany without any experimental interventions.)Many, like Mukpo, were given several treatments at the same time, making it hard to unravel the impact of anyone of them. The fact that they were taken care of in modern, well-staffed hospitals may also help explain why 75 % have survived. "Probably the best we can say is that the experimental treatments are not killing anyone," says Michael Kurllla, who heads the Office of Biodefense Research Resources and Translational Research at the National Institute of Allergy and Infectious Diseases(NIAID)in Roekville, Maryland.
Now, that’s about to change. As early as next month, researchers will begin trials in West Africa to find a solid answer to the key question: Do the treatments work? Carried out in makeshift e-mergency hospitals by researchers wearing full protective gear in the middle of a deadly epidemic, these will be some of the most unusual drug trials ever done. And they also raise major ethical and practical questions, some of which were intensely debated at a World Health Organization(WHO)meeting in Geneva, Switzerland, on November 11th and 12th. Perhaps the most important one: Is it right to do randomized controlled trials(RCTs), in which some people don’t get the novel intervention ? Doctors without Borders(MSF), which has led the medical response to the outbreak, says no—not with a disease as deadly as Ebola. Instead, on November 13th MSF said it will take part in three trials that will use an alternative design in which everyone who enrolls receives the untested treatment. But others argue that such setups may not give clear answers and squander a precious scientific opportunity.
It’s an uncomfortable and complex debate held under extreme time pressure. " Everyone has stepped outside of their comfort zone in a big way," says Peter Horby of the University of Oxford in the United Kingdom, who is leading one of the upcoming trials and attended the WHO meeting.
Questions 66 to 70
Answer the following questions with the information given in the passage.
What are the advantages and disadvantages of TKM-Ebola?
选项
答案
It can inhibit viral RNA and work beautifully in monkeys.But it could trigger overproduction ofcytokines,a dangerous inflammatory response also caused by the Ebola virus.
解析
(由关键词TKM-Ebola定位至第三段第二句。“has worked beautifully in monkeys”为该疗法的优点。该疗法的缺点在本段第七句明确给出。)
转载请注明原文地址:https://kaotiyun.com/show/QQfK777K
本试题收录于:
A类竞赛(研究生)题库大学生英语竞赛(NECCS)分类
0
A类竞赛(研究生)
大学生英语竞赛(NECCS)
相关试题推荐
Themajorpartofmychildhoodwasspentinfightingoffterrorofthingswhichdidn’texist,andIdon’tthinkmyfatherever
Themajorpartofmychildhoodwasspentinfightingoffterrorofthingswhichdidn’texist,andIdon’tthinkmyfatherever
MyentryintoBlackwomen’shistorywasunexpectedbutagreeable.IntheprefacetoBlackWomeninAmerica:AnHistoricalEncycl
MyentryintoBlackwomen’shistorywasunexpectedbutagreeable.IntheprefacetoBlackWomeninAmerica:AnHistoricalEncycl
随机试题
建设部《建筑业企业资质管理规定实施意见》明确《建筑业企业资质等级标准》中涉及水利方面的资质不包括()。
现代社会需要充分发挥每个人的主体性和创造性。因此美术课程特别重视对学生_______和_______的培养。[江苏2020]
下列叙述中哪项与异烟肼不符
对搭接、T型、套接、舌形与槽形接头形式均适用的焊接方法为()。
目前我国绝大部分个人投资者进行股票投资的主要目的是获得股利。()
以公允价值计量且其变动计入当期损益的金融资产,应当按照取得时的公允价值作为初始确认金额,相关交易赞用在发生时计入当期损益。()
学生走进教室时,黄老师正在准备演示实验。在教室的前面有一块金属板,正在加热一个铝制的罐头盒,热金属板的旁边有一盆冰水。上课铃响了,学生们还在说话,这时候黄老师用钳子夹起罐头盒将其倒置于冰水中。突然“砰”的一声巨响,盒子在冰水中冒出大量烟雾,学生们停止了讲话
我国政府采购的原则主要有()。
设循环队列为Q(1:m),初始状态为front=rear=m。现经过一系列的入队与退队运算后,front=rear=1,则该循环队列中的元素个数为
设x=4,y=8,z=7,则以下表达式的运算结果是()。xz)Orz
最新回复
(
0
)